\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\ \(399\)\
\-\ nil\ \(285\)\
\-\ transverse\\ image\\ of\\ left\\ kidney\\ showing\\ absence\\ of\\ hilar\\ fat\\ in\\ midpole\\.\ \(0\)\
\-\ coronal\\ view\\ confirmed\\ a\\ complete\\ band\\ of\\ renal\\ cortex\\-diagnostic\\ for\\ duplex\\ kidney\\.\ \(0\)\
\-\ faceless\\ kidney\\ sign\ \(4\)\
\-\ renal\\ duplication\ \(0\)\
\-\ hypertrophied\\ cloumn\\ of\\ bertin\\.\ \(0\)\
\-\ lobar\\ dysmorphism\ \(2\)\
\-\ nodular\\ compensatory\\ hypertrophy\ \(2\)\
\-\ segmental\\ infarction\ \(3\)\
\-\ pyelonephritis\ \(60\)\
\-\ infiltrative\\ diseases\ \(1\)\
\-\ tumors\\ like\\ transitional\\ cell\\ carcinoma\\ and\\ other\\ primary\\ tumors\ \(1\)\
\-\ routine\\ health\\ check\\ up\\ ultrasound\\.\ \(0\)\
\-\ ultrasound\\ equialent\\ of\\ \\'faceless\\ kidney\\ sign\\'\\.\ \(0\)\
\-\ hypertrophied\\ column\\ of\\ bertin\\ \\-these\\ are\\ group\\ of\\ renal\\ pseudotumors\\ characterised\\ by\\ focal\\ displacement\\ of\\ the\\ collecting\\ system\\ within\\ kidney\\ of\\ normal\\ contour\\.\ \(0\)\
\-\ they\\ usually\\ occur\\ in\\ the\\ presence\\ of\\ partial\\ or\\ complete\\ duplication\\ of\\ pelvicalyceal\\ system\\.\ \(0\)\
\-\ mass\\ effect\\ seen\\ most\\ frequently\\ \\,although\\ not\\ invariably\\ in\\ the\\ area\\ between\\ the\\ upper\\ and\\ inter\\ polar\\ areas\\ of\\ the\\ kidney\\.\ \(0\)\
\-\ in\\ many\\ instances\\ what\\ causes\\ this\\ mass\\ effect\\ is\\ normal\\ septal\\ cortex\\ tissue\\ that\\ has\\ persisted\\ during\\ lobar\\ fusion\\ and\\ in\\ the\\ process\\ has\\ become\\ relatively\\ prominent\\.\ \(0\)\
\-\ lobar\\ dysmorphism\\ \\-\\ this\\ is\\ another\\ form\\ of\\ pseudotumor\\ that\\ is\\ very\\ similar\\ to\\ large\\ cloison\\ \\.here\\ a\\ complete\\ though\\ diminutive\\ lobe\\ is\\ situated\\ atypically\\ deep\\ within\\ the\\ renal\\ substance\\.\ \(0\)\
\-\ as\\ with\\ septum\\ of\\ bertin\\ this\\ is\\ associated\\ with\\ duplication\\ of\\ the\\ collecting\\ system\\ and\\ will\\ focally\\ displace\\ the\\ pelvis\\ or\\ calyces\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ nodular\\ compensatory\\ hypertrophy\\ \\-in\\ the\\ presence\\ of\\ focal\\ renal\\ scarring\\ \\,\\ areas\\ of\\ unaffected\\ normal\\ renal\\ tissue\\ will\\ undergo\\ compensatory\\ hypertrophy\\.focal\\ enlargement\\ of\\ deeply\\ situated\\ septal\\ cortex\\ has\\ ben\\ described\\ in\\ analgesic\\ nephropathy\\.\ \(0\)\
\-\ lobar\\ infarction\\ \\-\\ edematous\\ phase\\ of\\ acute\\ renal\\ infarction\\ can\\ simulate\\ faceless\\ kidney\\ appearance\\.also\\ pyelonepritis\\ ca\\ n\\ cause\\ similar\\ appearance\\.doppler\\ sonography\\ will\\ show\\ these\\ aras\\ as\\ hypovascular\\.\ \(0\)\
\-\ tumors\\ \\-\\ renal\\ cell\\ carcinoma\\ \\,\\ and\\ aother\\ solid\\ tumors\\ of\\ kidney\\ including\\ metstasis\\ can\\ show\\ smilar\\ imaging\\ findings\\.\ \(0\)\
\-\ infiltrative\\ diseases\\ \\-neoplastic\\ cell\\ infiltration\\ generally\\ cause\\ bilateral\\ diffuse\\ renal\\ enlargement\\.however\\ rarely\\ leukemia\\ causes\\ unifocal\\ renal\\ mass\\ due\\ to\\ a\\ chloroma\\ \\,myeloblastoma\\,\\ myeloblastic\\ sarcoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.07924307251413794\ \(0\)\
\-\ kidney\\:\\ 0\\.07433045568024715\ \(0\)\
\-\ bertin\\:\\ 0\\.06360748402695542\ \(0\)\
\-\ lobar\\:\\ 0\\.060786396615504584\ \(0\)\
\-\ compensatory\\:\\ 0\\.056550631693187844\ \(0\)\
\-\ faceless\\:\\ 0\\.04763522305739746\ \(0\)\
\-\ dysmorphism\\:\\ 0\\.04585940779534943\ \(0\)\
\-\ duplication\\:\\ 0\\.04452023369198173\ \(0\)\
\-\ situated\\:\\ 0\\.041580721495596676\ \(0\)\
\-\ tumors\\:\\ 0\\.03962612787247532\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.033631003666543355\ \(0\)\
\-\ infarction\\:\\ 0\\.03233804115581564\ \(0\)\
\-\ system\\:\\ 0\\.031152592318525903\ \(0\)\
\-\ infiltrative\\:\\ 0\\.03026849023789106\ \(0\)\
\-\ septal\\:\\ 0\\.02874466259633843\ \(0\)\
\-\ complete\\:\\ 0\\.027846073462833836\ \(0\)\
\-\ cortex\\-diagnostic\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ cloumn\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ equialent\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ \\'faceless\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ characterised\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ cloison\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ \\.here\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ hypertrophy\\.focal\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ ben\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ appearance\\.also\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ appearance\\.doppler\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ aras\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ aother\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ metstasis\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ smilar\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ \\-neoplastic\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ enlargement\\.however\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ myeloblastoma\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ myeloblastic\\:\\ 0\\.027208390197427462\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.027139986519567283\ \(0\)\
\-\ collecting\\:\\ 0\\.026920809430327097\ \(0\)\
\-\ diseases\\:\\ 0\\.026571968626232397\ \(0\)\
\-\ nil\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ \\-these\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ pseudotumors\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ pelvicalyceal\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ inter\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ \\-in\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ pyelonepritis\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ unifocal\\:\\ 0\\.02506904704755109\ \(0\)\
\-\ will\\:\\ 0\\.024754453873880942\ \(0\)\
\-\ midpole\\:\\ 0\\.02381761152869873\ \(0\)\
\-\ atypically\\:\\ 0\\.02381761152869873\ \(0\)\
\-\ deeply\\:\\ 0\\.02381761152869873\ \(0\)\
\-\ analgesic\\:\\ 0\\.022929703897674715\ \(0\)\
\-\ cortex\\:\\ 0\\.022570760029333142\ \(0\)\
\-\ diminutive\\:\\ 0\\.022240989233124682\ \(0\)\
\-\ chloroma\\:\\ 0\\.022240989233124682\ \(0\)\
\-\ nodular\\:\\ 0\\.022125986463653772\ \(0\)\
\-\ invariably\\:\\ 0\\.021678268378822352\ \(0\)\
\-\ cell\\:\\ 0\\.021372599181310056\ \(0\)\
\-\ polar\\:\\ 0\\.021202494675651804\ \(0\)\
\-\ hypovascular\\:\\ 0\\.021202494675651804\ \(0\)\
\-\ similar\\:\\ 0\\.020689423573709186\ \(0\)\
\-\ causes\\:\\ 0\\.020534448751912415\ \(0\)\
\-\ displace\\:\\ 0\\.02010164608324831\ \(0\)\
\-\ simulate\\:\\ 0\\.02010164608324831\ \(0\)\
\-\ instances\\:\\ 0\\.019291879834891855\ \(0\)\
\-\ nephropathy\\:\\ 0\\.019291879834891855\ \(0\)\
\-\ presence\\:\\ 0\\.01914682480529092\ \(0\)\
\-\ unaffected\\:\\ 0\\.01906315152577543\ \(0\)\
\-\ substance\\:\\ 0\\.01885021056439595\ \(0\)\
\-\ effect\\:\\ 0\\.018676285512773116\ \(0\)\
\-\ sign\\:\\ 0\\.018274361122000437\ \(0\)\
\-\ cause\\:\\ 0\\.017847300163901025\ \(0\)\
\-\ areas\\:\\ 0\\.01774905661263004\ \(0\)\
\-\ check\\:\\ 0\\.017668135711753647\ \(0\)\
\-\ persisted\\:\\ 0\\.017668135711753647\ \(0\)\
\-\ focally\\:\\ 0\\.017668135711753647\ \(0\)\
\-\ duplex\\:\\ 0\\.017530938913695518\ \(0\)\
\-\ calyces\\:\\ 0\\.017530938913695518\ \(0\)\
\-\ \\-\\:\\ 0\\.016960448691744106\ \(0\)\
\-\ show\\:\\ 0\\.01619232058328164\ \(0\)\
\-\ transitional\\:\\ 0\\.016148146560217246\ \(0\)\
\-\ edematous\\:\\ 0\\.016148146560217246\ \(0\)\
\-\ column\\:\\ 0\\.015901101166163122\ \(0\)\
\-\ sonography\\:\\ 0\\.015672372857046694\ \(0\)\
\-\ ultrasound\\:\\ 0\\.01564890484571792\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.015391595763819144\ \(0\)\
\-\ scarring\\:\\ 0\\.015391595763819144\ \(0\)\
\-\ n\\:\\ 0\\.015325218587211233\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.015260238929193232\ \(0\)\
\-\ band\\:\\ 0\\.015196599153876146\ \(0\)\
\-\ focal\\:\\ 0\\.015064775334187666\ \(0\)\
\-\ carcinoma\\:\\ 0\\.014950170802567076\ \(0\)\
\-\ has\\:\\ 0\\.014858333060132203\ \(0\)\
\-\ health\\:\\ 0\\.01462339808660734\ \(0\)\
\-\ infiltration\\:\\ 0\\.014372331298169215\ \(0\)\
\-\ what\\:\\ 0\\.01392423867519237\ \(0\)\
\-\ segmental\\:\\ 0\\.0138419292706178\ \(0\)\
\-\ group\\:\\ 0\\.013722440035492212\ \(0\)\
\-\ leukemia\\:\\ 0\\.01353302970717032\ \(0\)\
\-\ septum\\:\\ 0\\.013496503603321547\ \(0\)\
\-\ \\'\\:\\ 0\\.013389449412000898\ \(0\)\
\-\ undergo\\:\\ 0\\.013389449412000898\ \(0\)\
\-\ hilar\\:\\ 0\\.01325225261394277\ \(0\)\
\-\ contour\\:\\ 0\\.012786078979952443\ \(0\)\
\-\ rarely\\:\\ 0\\.012645122076146306\ \(0\)\
\-\ become\\:\\ 0\\.012563537949392741\ \(0\)\
\-\ tissue\\:\\ 0\\.012502599928719714\ \(0\)\
\-\ phase\\:\\ 0\\.012406567525832583\ \(0\)\
\-\ normal\\:\\ 0\\.01240381902406575\ \(0\)\
\-\ form\\:\\ 0\\.012330977957905744\ \(0\)\
\-\ ca\\:\\ 0\\.012281594188317963\ \(0\)\
\-\ though\\:\\ 0\\.012232988148292842\ \(0\)\
\-\ like\\:\\ 0\\.01220896919631119\ \(0\)\
\-\ showing\\:\\ 0\\.01213801389314854\ \(0\)\
\-\ can\\:\\ 0\\.01196433550906833\ \(0\)\
\-\ generally\\:\\ 0\\.011869460260464497\ \(0\)\
\-\ fusion\\:\\ 0\\.011764111475373576\ \(0\)\
\-\ sarcoma\\:\\ 0\\.011743466450216797\ \(0\)\
\-\ frequently\\:\\ 0\\.011430650109907268\ \(0\)\
\-\ another\\:\\ 0\\.01133905823291308\ \(0\)\
\-\ displacement\\:\\ 0\\.011303169226755306\ \(0\)\
\-\ relatively\\:\\ 0\\.011285380014666571\ \(0\)\
\-\ described\\:\\ 0\\.011232619417878608\ \(0\)\
\-\ mass\\:\\ 0\\.01100426858284782\ \(0\)\
\-\ coronal\\:\\ 0\\.010981552629440483\ \(0\)\
\-\ absence\\:\\ 0\\.010965519244017322\ \(0\)\
\-\ many\\:\\ 0\\.010840165172553772\ \(0\)\
\-\ prominent\\:\\ 0\\.010824847921497818\ \(0\)\
\-\ deep\\:\\ 0\\.010675716510168165\ \(0\)\
\-\ transverse\\:\\ 0\\.010575452759722213\ \(0\)\
\-\ routine\\:\\ 0\\.010575452759722213\ \(0\)\
\-\ partial\\:\\ 0\\.01054739420508872\ \(0\)\
\-\ solid\\:\\ 0\\.010519588433661664\ \(0\)\
\-\ enlargement\\:\\ 0\\.010464717303966344\ \(0\)\
\-\ process\\:\\ 0\\.01015452310134171\ \(0\)\
\-\ within\\:\\ 0\\.010062539557938776\ \(0\)\
\-\ confirmed\\:\\ 0\\.009917900009527152\ \(0\)\
\-\ view\\:\\ 0\\.009895205644387464\ \(0\)\
\-\ occur\\:\\ 0\\.009895205644387464\ \(0\)\
\-\ pelvis\\:\\ 0\\.009583615452443298\ \(0\)\
\-\ very\\:\\ 0\\.00957341240264546\ \(0\)\
\-\ including\\:\\ 0\\.009522897040101617\ \(0\)\
\-\ they\\:\\ 0\\.00950292014347934\ \(0\)\
\-\ that\\:\\ 0\\.009110992151597674\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.008915408635790392\ \(0\)\
\-\ although\\:\\ 0\\.00890718913758211\ \(0\)\
\-\ this\\:\\ 0\\.008899418641797528\ \(0\)\
\-\ is\\:\\ 0\\.008677326826924778\ \(0\)\
\-\ between\\:\\ 0\\.0083595541241489\ \(0\)\
\-\ area\\:\\ 0\\.008339000753500823\ \(0\)\
\-\ image\\:\\ 0\\.008238238167585187\ \(0\)\
\-\ during\\:\\ 0\\.008071016203468543\ \(0\)\
\-\ fat\\:\\ 0\\.008021334329881584\ \(0\)\
\-\ usually\\:\\ 0\\.008009037820576416\ \(0\)\
\-\ diffuse\\:\\ 0\\.007984590803627515\ \(0\)\
\-\ as\\:\\ 0\\.007978873493173628\ \(0\)\
\-\ primary\\:\\ 0\\.007812914391653384\ \(0\)\
\-\ in\\:\\ 0\\.007803652410004721\ \(0\)\
\-\ of\\:\\ 0\\.0071915926418511375\ \(0\)\
\-\ lobe\\:\\ 0\\.0070966831726034995\ \(0\)\
\-\ up\\:\\ 0\\.007092120836587109\ \(0\)\
\-\ due\\:\\ 0\\.007037892447385307\ \(0\)\
\-\ these\\:\\ 0\\.006863718185055062\ \(0\)\
\-\ acute\\:\\ 0\\.00651197323798301\ \(0\)\
\-\ bilateral\\:\\ 0\\.006400672004056925\ \(0\)\
\-\ upper\\:\\ 0\\.006364446004224439\ \(0\)\
\-\ associated\\:\\ 0\\.006223649882431178\ \(0\)\
\-\ or\\:\\ 0\\.006182239191133997\ \(0\)\
\-\ imaging\\:\\ 0\\.006179240198937045\ \(0\)\
\-\ most\\:\\ 0\\.00608899735101258\ \(0\)\
\-\ other\\:\\ 0\\.006079131323155705\ \(0\)\
\-\ large\\:\\ 0\\.005767106271083579\ \(0\)\
\-\ findings\\:\\ 0\\.005613694246265307\ \(0\)\
\-\ seen\\:\\ 0\\.00521181362675213\ \(0\)\
\-\ by\\:\\ 0\\.004391576861866897\ \(0\)\
\-\ the\\:\\ 0\\.004266953231593389\ \(0\)\
\-\ \\,\\:\\ 0\\.004177624467859373\ \(0\)\
\-\ not\\:\\ 0\\.003811168739944245\ \(0\)\
\-\ a\\:\\ 0\\.0036722203872092706\ \(0\)\
\-\ are\\:\\ 0\\.0035952897300296346\ \(0\)\
\-\ left\\:\\ 0\\.0029509421891139344\ \(0\)\
\-\ and\\:\\ 0\\.002777916755126828\ \(0\)\
\-\ to\\:\\ 0\\.0026362228916233716\ \(0\)\
\-\ for\\:\\ 0\\.0022503337921071453\ \(0\)\
\-\ \\.\\:\\ 0\\.001643497041543809\ \(0\)\
\-\ with\\:\\ 0\\.0007222480005548749\ \(0\)\
